GenScript

Piscataway, NJ / Nanjing, China
Find alternatives to GenScript for CAR-T →
Program data pending ClinicalTrials.gov matching · Last scored 2026-10-29
64.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (19) ○ EMA GMP ○ MHRA GMP

Quick Facts: GenScript

Signal Score
64.0/100 (as of 2026-10-29)
Quality Compliance
Assessment pending
Headquarters
Piscataway, NJ / Nanjing, China
Modalities
CAR-T, Cell Therapy, Gene Editing
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About GenScript

BIOSECURE Act exposure via China operations.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesCAR-T, Cell Therapy, Gene Editing
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 65.0
Publicly traded — financial transparency
BIOSECURE Act exposure risk
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Publicly traded — financial transparency
BIOSECURE Act exposure risk
Capacity 63.0
2 manufacturing sites
Sites: Piscataway, NJ, Nanjing, China
Source: company profiles (manufacturing sites, modality breadth)
2 manufacturing sites
Press Signals19 articles (not scored)
2 manufacturing sites

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No count for this company yet. The careers board we can read covers more than this business (85 postings on Nov 21, 2026), and we can't yet tell which of those roles belong to it. Why: the board covers the whole group and doesn't say which business unit a role belongs to. We'd rather show no number than one that isn't really this company's.
Source: greenhouse · Checked Nov 21, 2026

Company Signals 19 articles

Company announcements, not verified evidence. They do not change any score.
general 2026-04-21
GenScript Biotech rose more than 5% in early trading as Eli Lilly and Co announced a $7 billion acquisition of an in vivo CAR-T company. - 富途牛牛
GenScript Biotech rose more than 5% in early trading as Eli Lilly and Co announced a $7 billion acquisition of an in vivo CAR-T company.  富途牛牛
regulatory 2026-04-10
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - BioSpace
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era  BioSpace
regulatory 2026-04-10
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - Dailyhunt
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era  Dailyhunt
regulatory 2026-04-09
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - The Manila Times
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era  The Manila Times
regulatory 2026-04-09
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - Thailand Business News
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era  Thailand Business News
regulatory 2026-04-09
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - Bolsamania
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era  Bolsamania
regulatory 2026-04-09
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - TNGlobal
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era  TNGlobal
general 2026-03-17
GenScript reports strong fiscal 2025 results from platform strategy - Vietnam Investment Review - VIR
GenScript reports strong fiscal 2025 results from platform strategy  Vietnam Investment Review - VIR
regulatory 2026-03-16
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership - Indian Pharma Post
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership  Indian Pharma Post
general 2026-03-16
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth - Bolsamania
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth  Bolsamania
regulatory 2026-03-16
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership - Indian Pharma Post
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership  Indian Pharma Post
regulatory 2026-03-15
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership - Indian Pharma Post
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership  Indian Pharma Post
general 2026-03-13
GenScript opens its first European mRNA production site - Scientist Live
GenScript opens its first European mRNA production site  Scientist Live
general 2026-03-13
GenScript opens its first European mRNA production site - Scientist Live
GenScript opens its first European mRNA production site  Scientist Live
general 2026-03-12
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub - BioSpace
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub  BioSpace
general 2026-03-12
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub - The AI Journal
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub  The AI Journal
general 2026-03-12
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub - BeBeez International
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub  BeBeez International
general 2026-03-12
GenScript Opens First European mRNA Production Facility In Delft Strengthening Global Biotechnology Platform - BioPharma APAC
GenScript Opens First European mRNA Production Facility In Delft Strengthening Global Biotechnology Platform  BioPharma APAC
general 2026-03-12
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub - TNGlobal
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub  TNGlobal

Frequently Asked Questions About GenScript

What is GenScript's CDMO Signal Score?
GenScript has a Signal Score of 64/100, based on quality, operations, financial stability, and capacity data.
Evaluating GenScript for a manufacturing program?
Use the free AI matchmaker to compare GenScript against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
CAR-T CDMOs → Cell Therapy CDMOs → Gene Editing CDMOs →

Similar CDMOs

Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
RoslinCT
Edinburgh, UK · Hopkinton, MA
Signal Score: 79.3
CAR-T, Cell Therapy, iPSC, Gene Editing
CTMC
Houston, TX
Signal Score: 63.0
CAR-T, Cell Therapy, Gene Editing
Poseida Therapeutics (CDMO)
San Diego, CA
Signal Score: 58.7
CAR-T, Cell Therapy, Gene Editing
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 87.0
CAR-T, Cell Therapy

Compare GenScript with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on GenScript
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.